Cash · 2011–2025
TG Therapeutics cash
$79.1M−56.0% · FY2025
TG Therapeutics (TGTX) reported $79.1M in cash for fiscal 2025, −56.0% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $79.1M | −56.0% | Open → |
| FY20242024-12-31 | $180M | +93.6% | Open → |
| FY20232023-12-31 | $92.9M | −9.2% | Open → |
| FY20222022-12-31 | $102M | −65.8% | Open → |
| FY20212021-12-31 | $299M | −46.0% | Open → |
| FY20202020-12-31 | $553M | +391.3% | Open → |
| FY20192019-12-31 | $113M | +168.5% | Open → |
| FY20182018-12-31 | $42.0M | −26.0% | Open → |
| FY20172017-12-31 | $56.7M | +126.6% | Open → |
| FY20162016-12-31 | $25.0M | −54.5% | Open → |
| FY20152015-12-31 | $55.1M | −1.2% | Open → |
| FY20142014-12-31 | $55.7M | +37.6% | Open → |
| FY20132013-12-31 | $40.5M | +146.0% | Open → |
| FY20122012-12-31 | $16.5M | +68.8% | Open → |
| FY20112011-12-31 | $9.7M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.1%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=TG Therapeutics cash |url=https://companiesranked.com/en/company/tg-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). TG Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/tg-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-tg-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{TG Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/tg-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001437749-26-025955 · August 5, 2026
{{cite web |title=TG Therapeutics cash — 10-Q (0001437749-26-025955) |url=https://www.sec.gov/Archives/edgar/data/1001316/000143774926025955/tgtx20260630_10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.